Emilio Frazzoli, MIT Professor of Aeronautics & Astronautics, nuTonomy CTO
MIT Startup Exchange is looking for 3-4 startup speakers to participate in a pre-recorded webcast on April 29 and a possible follow-up live event on May 4, both focused on work of the future.
We are looking to partner with experts to find, develop, and validate selective solutions that can target and efficiently remove targeted constituents from mine-influenced water (MIW) to enhance water recovery, reduce residual wastes, and the recovery of resources to generate new revenue streams and offset closure costs.
P&G is seeking innovative chemistry to help us reduce impact in the use phase (superior performance in cold water) and/ or ingredients with positive/ neutral carbon footprint impact.
MIT Startup Exchange is convening the workshop on 3/26, 11am, to showcase the best of MIT Startups in Digital Health.
Proctor & Gamble would like to partner with startups that have technology to allow creative teams to upload Adobe InDesign/other creative output files into navigable web experience.
P&G is looking for startups to build new, cost-effective, data-based pipelines to reach the store owners and expand P&G exposure to them, and therefore P&G’s sales and assortment.
At our annual MIT Startup Ecosystem Conference, we celebrate innovation and bring together its many contributors: entrepreneurs, corporates, and university researchers, as well as government representatives, investors, and those involved with incubators and accelerators. We will assemble to discuss creating, supporting, and scaling new ventures and how to increase productivity and competitive advantage. Aligned with the emphasis of MIT Startup Exchange, we will focus on the startup-corporate relationship. Topics will include pain points, valleys of death, and strategies to avoid as well as how to overcome the stones found along the way.
As always, this event features executives from some of the most promising startups connected to MIT who will present lightning talks in two fast-paced sessions, each followed by an opportunity to have direct discussions.
Many consider this conference a must-attend for innovators and executives at industry-leading corporations, especially those working in innovation, emerging technology, corporate venture capital, and/or corporate development/strategy.
Hear from distinguished MIT faculty and startups on topics such as recent advances in precision medicine for a more targeted and personalized treatment, immunotherapy to fight cancer cells, gene therapy, AI to improve diagnosis, treatment, and patient outcomes, and more.